Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Natalizumab

Immune thrombocytopenic purpura: case report

    • 17 Accesses

    This is a preview of subscription content, log in to check access.

    REFERENCE

    1. 1.

      Stosic M, De Jesus P, McCarthy J, Hutton G, Rivera V.Immune thrombocytopenic purpura in a patient with multiple sclerosis treated with natalizumab. Neurology 77: 505-507, No. 5, 2 Aug 2011. Available from: URL: http://dx.doi.org/10.1212/wnl.0b013e318227b23f - USA

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Natalizumab. React. Wkly. 1370, 28 (2011). https://doi.org/10.2165/00128415-201113700-00096

    Download citation

    Keywords

    • Multiple Sclerosis
    • Thrombocytopenia
    • Prednisone
    • Lower Extremity
    • Complete Blood Count